Xenetic Biosciences, Inc. (XBIO)
2.44
+0.02
(+0.83%)
USD |
NASDAQ |
Dec 12, 16:00
2.43
-0.01
(-0.41%)
Pre-Market: 20:00
Xenetic Biosciences Cash from Financing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 88.06M |
| Travere Therapeutics, Inc. | -65.34M |
| KalVista Pharmaceuticals, Inc. | -- |
| BeyondSpring, Inc. | 0.2795M |
| Solid Biosciences, Inc. | 1.176M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.6582M |
| Free Cash Flow | -2.718M |
| Free Cash Flow Per Share (Quarterly) | -0.4268 |
| Free Cash Flow to Equity (Quarterly) | -0.6582M |
| Free Cash Flow to Firm (Quarterly) | -0.6582M |
| Free Cash Flow Yield | -72.23% |